Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound are pointed out in brand-new standards from United States cardiologists as medicines to take into consideration for avoiding heart disease.
发布者:BY MARKETWIRE,转转请注明出处:https://robotalks.cn/novos-weight-loss-drug-approved-by-us-cardiologists/